Abstract
The need for anticoagulants during pregnancy is a challenging problem for the clinician. The use of heparin versus coumarin and different intensities of anticoagulation for diverse thrombotic processes along the gestational period have a spectrum of risks for the mother and child and the benefits of various anticoagulant regimens are not well defined.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
An International Multicenter Trial. Prevention of fatal postoperative pulmonary embolism by low dose heparin. Lancet 45–51, 1975.
Artur CK, Isbister JP, Aspery EM. The heparin induced thrombosis-thrombocytopenia syndrome (H.I.T.T.S.): A review. Pathology 17, 82–86, 1985.
Buxbaum A, Aygen MM, Shahin W et al. Pregnancy in patients with prosthetic heart valves. Chest 59, 639–642, 1971.
Bynum LJ, Wilson JE. Low-dose heparin therapy in long-term management of venous thromboembolism. Am J Med 67, 553–556, 1979.
Dalen JE, Hirsh J. American College of Chest Physicians and the National Heart, Lung and blood Institute National Conference on Antithrombotic Therapy. Arch Intern Med 146, 462–472, 1986.
Derek JK, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 100, 535–540, 1984.
Gervin AS. Complications of heparin therapy. Surg Gynecol Obstet 140, 789–796, 1975.
Ginsberg JS, Hirsh J. Anticoagulants during pregnancy. Ann Rev Med 40, 79–86, 1989.
Griffith GC, Nichols G Jr, Asher JD et al. Heparin osteoporosis. JAMA 193, 91–94, 1965.
Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68, 122–140, 1980.
Hellgren M, Hygards EB. Long-term therapy with subcutaneous heparin during pregnancy. Gynecol Obstet Invest 13, 76–89, 1982.
Hirsh J. Heparin. N Engl J Med 324, 1565–1574, 1991.
Hirsh J. Oral anticoagulant drugs. N Engl J Med 324, 1865–1875, 1991.
Howell R, Fidler J, Letsky E, De Sweit M. The risk of antenatal heparin prophylaxis: a controlled trial. Br J Obstet Gynecol 90, 1124–1128, 1983.
Hull R, Delmore T, Carter C, Hirsh J, Genton E, Gent M, Turpie G, McLaughlin D. Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. N Engl J Med 306, 189–194, 1982.
Ibarra-Perez C, Arevalo-Toledo N et al, The course of pregnancy in patients with Iturbe Alessio 307 artificial heart valves. Am J Med 61, 504–512, 1976.
Iturbe-Alessio I, Fonseca MC, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 315, 1390–1393, 1986.
Javares T, Coto EO, Maiquez V, Rincon A, Such M, Caffarena JM. Pregnancy after heart valve replacement. Int J Cardiol 5, 731–746, 1984.
King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 100, 535–540, 1984.
Larrea JL, Nunez L, Reque JA, Gil Aguado M, Matarros R, Minguez JA. Pregnancy and mechanical valve prostheses: a high risk situation for the mother and fetus. Ann Thorac Surg 36, 459–463, 1983.
Loegher E, ICSH/ICTH. Recommendations for reporting prothrombin time in oral anticoagulant control. Thromb Haemost 53, 155–156, 1985.
Oakley C. Valve prosthesis and pregnancy. Br Heart J 58, 303–305, 1987.
Pauli RM, Hall JG. Wilson KM. Risks of anticoagulation during pregnancy. Am Heart J 100, 761–762, 1980.
Pridmore BR, Murray KH, Mc Allen PM. The mamangement of anticoagulant therapy during and after pregnancy. Br J Obstet Gynaecol 82, 740–744, 1975.
Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prosthesis, anticoagulants and pregnancy. Circulation 70(1), 169–177, 1984.
Sareli P, England MJ, Berk MR, Marcus RH, Epstein M, Driscoll J, Meyer T, McINTYRE J, Van Gelderen C. Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prosthesis. Am J Cardiol 63, 1462–1465, 1989.
Schaffer AT. The hypercoagulable states. Ann Intern Med 102, 814–828, 1985.
Shaul WL, Hall JG. Multiple congenital anomalies associated with oral anticoagulants. Am J Obstet Gynecol 127, 191–198, 1977.
Wang RYC, Pui Kee Lee et al. Efficacy of low-dose, subcutaneously administered heparin in treatment of pregnant women with artificial heart valves. Med J Aust 2, 126–128, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Iturbe Alessio, I. (1994). Anticoagulants in pregnancy. In: Doutremepuich, C. (eds) Anticoagulation. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2668-0_15
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2668-0_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7627-2
Online ISBN: 978-1-4612-2668-0
eBook Packages: Springer Book Archive